UCSD’s Center for Novel Therapeutics brings cancer researchers, industry, together
Structurally, UC San Diego’s new Center for Novel Therapeutics is a 137,500-square-foot building. But functionally, it’s a bridge.
Cancer therapies are intended to travel across that bridge, starting as research at UCSD Moores Cancer Center, and crossing over into full-fledged therapies. Moores Cancer Center and private companies are to partner in that research-to-therapy transition.
The center arose as a partnership between the university and BioMed Realty, a life-science commercial real estate company. BioMed Realty spent $92 million on the building.